Australia is eagerly anticipating the arrival of retatrutide, a novel dual GIP and GLP-1 receptor medication , representing a significant advance in addressing excess weight. Early study data have demonstrated https://giant-gravel-bike161142.wikilima.com/2613690/emerging_medication_in_australia_a_potential_solution_for_weight_loss